PubRank

Shirish Gadgeel

Author PubWeight™ 25.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies. J Clin Oncol 2005 2.32
2 Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer. J Clin Oncol 2007 2.16
3 Chronic obstructive lung diseases and risk of non-small cell lung cancer in women. J Thorac Oncol 2009 1.74
4 An educational video to increase clinical trials enrollment among lung cancer patients. J Thorac Oncol 2008 1.58
5 Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer. J Clin Oncol 2013 1.55
6 Phase I and pharmacokinetic study of lapatinib and docetaxel in patients with advanced cancer. J Clin Oncol 2008 1.37
7 Up-regulation of sonic hedgehog contributes to TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS One 2011 1.30
8 Percutaneous cryoablation of metastatic lesions from non-small-cell lung carcinoma: initial survival, local control, and cost observations. J Vasc Interv Radiol 2012 1.24
9 Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer. J Thorac Oncol 2011 1.23
10 An educational video to increase clinical trials enrollment among breast cancer patients. Breast Cancer Res Treat 2009 1.11
11 Analysis and reproducibility of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancer. Clin Cancer Res 2008 0.96
12 A phase I study of flavopiridol and docetaxel. Invest New Drugs 2006 0.94
13 Phase I study of bryostatin 1 and gemcitabine. Clin Cancer Res 2006 0.91
14 The natural tumor suppressor protein maspin and potential application in non small cell lung cancer. Curr Pharm Des 2010 0.88
15 A phase 2 study of TZT-1027, administered weekly to patients with advanced non-small cell lung cancer following treatment with platinum-based chemotherapy. Lung Cancer 2006 0.86
16 A phase 1 trial of XK469: toxicity profile of a selective topoisomerase IIbeta inhibitor. Invest New Drugs 2006 0.85
17 Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study. Invest New Drugs 2010 0.85
18 Mature results of a phase II trial of gemcitabine/paclitaxel given every 2 weeks in patients with advanced non-small-cell lung cancer. Clin Lung Cancer 2007 0.82
19 Radioprotection of lung tissue by soy isoflavones. J Thorac Oncol 2013 0.82
20 Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma. Radiother Oncol 2013 0.82
21 Cost-effectiveness and lung cancer clinical trials. Cancer 2003 0.79
22 Glucocorticoid receptor status is a principal determinant of variability in the sensitivity of non-small-cell lung cancer cells to pemetrexed. J Thorac Oncol 2014 0.78